This compound is a pharmaceutical intermediate specifically used in the manufacturing of Velpatasvir, a direct-acting antiviral agent. It is a sterically defined pyrrolidine derivative containing multiple ether and ester functional groups, as well as a tetrahydronaphthoisochromenone moiety.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1378391-39-9
(2S,4S)-2-(2-(9-Bromo-8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen-3-yl)-2-oxoethyl) 1-tert-butyl 4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate
Velpatasvir synthetic intermediate
1,2-Pyrrolidinedicarboxylic acid, 4-cyano-, 1-(1,1-dimethylethyl) 2-methyl ester, (2S,4S)-
Pharmaceutical intermediate for Velpatasvir
9-bromo-3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
Pharmaceutical intermediate for Velpatasvir
3-acetyl-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
Pharmaceutical intermediate for Velpatasvir
(5s)-1-(tert-butoxycarbonyl)-5-methyl-l-proline
Pharmaceutical intermediate for Velpatasvir
L-Proline, N-(methoxycarbonyl)-L-valyl-5-methyl-, 3-[2-[[[(2S,4S)-1-[(1,1-dimethylethoxy)carbonyl]-4-(methoxymethyl)-2-pyrrolidinyl]carbonyl]oxy]acetyl]-8,9,10,11-tetrahydro-8-oxo-5H-benzo[d]naphtho[2,3-b]pyran-9-yl ester, (5S)-
Velpatasvir intermediate
Tert-butyl (2S,4S)-2-[5-[6-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,11,14(19),15,17-octaen-17-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate
Velpatasvir intermediate
Tert-butyl (2S,4S)-2-[5-[6-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate
Pharmaceutical intermediate for Velpatasvir synthesis
1-O-tert-butyl 2-O-[2-oxo-2-(8-oxo-5,9,10,11-tetrahydronaphtho[2,3-c]isochromen-3-yl)ethyl] (2S,4S)-4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate
RRSPSQSLZMAUSZ-BVZFJXPGSA-N
CC(C)(C)OC(=O)N1C[C@H](C[C@H]1C(=O)OCC(=O)C2=CC3=C(C=C2)C4=C(C=C5C(=C4)CCCC5=O)OC3)COC
—